Mark Legaz

Dr. Mark Legaz is the President and CEO of Intersect Systems, Inc., a medical diagnostic products company, and is the Founder and Consultant to Catch, Inc, of Seattle, Washington, whose diagnostic technologies were acquired by Axis-Shield of Scotland. Dr. Legaz is a research biochemist with over 40 years of academic and corporate experience. He has developed and obtained FDA clearance for over 20 reagent formulations utilizing acombination of mammalian and microbial enzymes. Products developed by Dr. Legaz’s ventures,are sold by Bayer, Olympus, Beckman, Roche, Genzyme, Medical AnalysisSystems, Johnson and Johnson, Techniconand Carolina Liquid Chemistries. Dr. Legaz has numerous peer-reviewed publications. He received a B.A. inchemistry from the University of San Diego, California; a Ph.D. in biochemistry from the University of Washington in Seattle; and did his post doctorial research in clinical chemistry at the University of Washington.